Global venture funding reached $159 billion in Q3 2026 with 27 record billion-dollar rounds driven by AI competition. This week's top deals were dominated by artificial intelligence, with Instinct closing a $1 billion mega-round. Health tech continues to attract significant capital with Rightway securing $155 million for pharmacy benefits technology.
AI dominance continues to define VC markets: Instinct's $1 billion mega-round and EliseAI's $350 million financing lead this week's funding surge, with healthcare and housing tech emerging as hot verticals. Global venture investment is on track to hit $1 trillion in 2026, driven by record exit activity and investor appetite for AI-powered infrastructure. <!-- /headline --> AI Infrastructure Eating Enterprise Software—And Raising Billion-Dollar Rounds <!-- /headline -->
The week ending September 30 saw $2.5B+ in notable funding rounds across physical AI, robotics sensors, and fintech, with a clear shift toward autonomous systems and real-world AI applications. Peak XV's Surge fund doubled its seed investment ceiling to $5M, signaling confidence in early-stage deep-tech founders. Meanwhile, IPO postponements are accelerating in Q3, complicating the exit landscape for mature startups.
Global funding this week was dominated by two $400M rounds for cybersecurity unicorns, alongside large financings in AI, drug discovery, neurotech, and climate tech. The standout: the fortress-style enterprise-security category1 continuing to attract mega-checks as AI raises the enterprise security stakes. Venture capital is clustering around companies that control hard bottlenecks rather than adding application layers.
Venture funding this week continued to rotate toward infrastructure-layer AI — security, governability, and enterprise enablement — rather than foundational models themselves. The standout deal was cybersecurity firm Cyera's $400 million raise, while Ema's $77M round underscored investor appetite for AI eating into enterprise software. Nursery-week deal flow remains strong in the US, which logged 32 rounds worth $6.54B in the most recent tracked week.
Venture money is flowing out of thin AI application layers and into physical infrastructure — weather modification, nuclear power, domestic AI chips, and energy systems led the past 24 hours of deal activity. Weekly aggregates show 20 funds raising $6.52B while 126 rounds deployed $11.1B across the market. NYC's early-stage scene stayed active with Luzern Risk and Clarion Health among the names out of AlleyWatch's daily report.
Venture capital is shifting from pure AI hype to funding the "bottlenecks" of AI scaling, with notable deals in AI infrastructure, sovereign chips, and power systems. Crypto VC funding saw a 31% rebound in Q2 2026, totaling $5.7 billion, while biotech and health-tech continue to attract significant late-stage capital. The market remains highly selective, with investors focusing on companies that control critical resources and industry-specific workflows.
Global venture capital activity remains robust with a record $510 billion invested in the first half of 2026, driven primarily by AI and physical infrastructure. This week, standout deals include Harvey’s massive $550 million round at a $15.5 billion valuation and Bluecore Energy’s $50 million seed raise, signaling continued investor appetite for high-growth AI and nuclear energy startups. <!-- /headline --> **Legal AI Harvey Hits $15.5B Valuation in Massive New Round** <!-- /headline -->
Global venture funding accelerated significantly in August 2026, with Crunchbase data showing a 122% month-over-month jump driven by a streak of billion-dollar deals. The week’s standout activity highlights a continued dominance of AI-driven solutions across diverse sectors, from space manufacturing to medical diagnostics, alongside notable seed and growth rounds in fintech and health tech. <!-- /headline --> **Global VC Funding Jumps 122% as AI Megadeals Continue** <!-- /headline -->
Global venture funding continues its historic run with a record $510 billion raised in H1 2026, driven overwhelmingly by AI infrastructure and physical AI. This week, capital concentrated in biotech therapeutics and hard-tech deployment solutions, with AusperBio’s $120M Series C leading a shift toward financing complex, real-world problems rather than broad software promises. <!-- /headline --> **Hard Tech and Biotech Lead as AI Bottlenecks Drive Funding** <!-- /headline -->
Global venture funding continues to surge, with the week ending August 22, 2026, recording $3.9 billion in new startup capital across 34 notable deals. The standout transaction is XPeng’s robotics unit, which raised over $900 million in its first external round, signaling a massive pivot toward physical AI infrastructure. Capital flows remain heavily concentrated in AI and physical infrastructure, with significant activity also observed in Indian fintech and African venture ecosystems.
Venture capital is shifting its focus from generic AI software to deeper infrastructure, with investors backing energy efficiency, specialized silicon, and physical AI. Global venture funding in the physical AI space alone reached $47.4 billion in the first half of 2026, a nearly 4x increase from the second half of 2025. This week's standout deals include a new $5 billion round for Databricks and significant capital flowing into AI neolabs and defense.
Global venture funding continues its momentum with AI infrastructure commanding the largest capital allocation this week, as major fund closings and strategic exits reshape the market landscape. Israeli startups raised $1.5 billion in July, signaling strong enterprise AI adoption, while Index Ventures closed a significant $2 billion across three new funds following a landmark portfolio exit.
Global venture funding remains robust as AI dominates capital flows. This week, enterprise infrastructure and AI systems companies closed significant rounds, with Fireworks AI's $1.5B Series D standing out. AI continues to account for nearly 80% of US venture capital, signaling sustained investor conviction in the sector despite market maturation.
Over $623 million in disclosed funding flowed across the top 10 startup rounds globally in the past week, driven by AI-focused infrastructure and enterprise security deals. Insurance startup Corgi hit a remarkable $4B valuation in its third funding round in eight weeks, signaling unprecedented velocity in mega-round financing. AI and defense tech continue to dominate capital allocation, with Anduril pursuing a potential $100B valuation.
Global venture funding continues its AI-driven acceleration, with Nous Research securing new capital at a $1.5B valuation and Emergent AI hitting unicorn status. Robotics and infrastructure startups are capturing significant capital alongside traditional software, signaling a broadening of the AI opportunity beyond pure software plays.
Global venture funding reached record pace with $510B deployed in H1 2026, driven by AI concentration and a surge in mega-deals. Emergent, an Indian AI coding startup, became a unicorn with a $130M Series C, exemplifying the week's dominant trend: AI infrastructure and software platforms that automate complex enterprise workflows now command investor attention across geographies.
Global venture funding hit record $510 billion in H1 2026, with Q2 2026 marking the second-largest quarter on record. However, the market shows stark bifurcation: mega-deals in AI dominate while seed funding contracts 27%, signaling a K-shaped startup ecosystem where mega-funds capture 72% of all capital raised.
Global startup funding hit a record $510 billion in H1 2026, with Q2 reaching $205 billion, though concentration in two AI labs (OpenAI and Anthropic) accounted for 43% of all capital. Almost 90 new unicorns have been minted so far this year as infrastructure and specialized AI hardware replace pure AI plays as investor priorities.
Q2 2026 marked a landmark quarter for startup exits, with more $1B+ liquidity events than any period since 2021, signaling strong momentum for later-stage investors. AI infrastructure and healthcare tech dominate fresh funding, while biotech rounds exceed $50M as VCs increasingly back proven, revenue-generating businesses. The week saw mixed signals: robust exit activity versus selective, quality-focused early-stage capital deployment.
Create custom signals on any topic. AI curates and delivers 24/7.
Create SignalPowered by
